Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 447-453 , December 2009

Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer

  • Christina T. Muijs

      Affiliations

    • Department of Radiation Oncology, University Medical Centre Groningen/University of Groningen, The Netherlands
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, University Medical Centre Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands.
    • ,
  • Liesbeth M. Schreurs

      Affiliations

    • Department of Surgical Oncology, University Medical Centre Groningen/University of Groningen, The Netherlands
    • ,
  • Dianne M. Busz

      Affiliations

    • Department of Radiation Oncology, University Medical Centre Groningen/University of Groningen, The Netherlands
    • ,
  • Jannet C. Beukema

      Affiliations

    • Department of Radiation Oncology, University Medical Centre Groningen/University of Groningen, The Netherlands
    • ,
  • Arnout J. van der Borden

      Affiliations

    • Department of Radiation Oncology, University Medical Centre Groningen/University of Groningen, The Netherlands
    • ,
  • Jan Pruim

      Affiliations

    • Department of Nuclear Medicine and Molecular Imaging, University Medical Centre Groningen/University of Groningen, The Netherlands
    • ,
  • Eric J. Van der Jagt

      Affiliations

    • Department of Radiology, University Medical Centre Groningen/University of Groningen, The Netherlands
    • ,
  • John Th. Plukker

      Affiliations

    • Department of Surgical Oncology, University Medical Centre Groningen/University of Groningen, The Netherlands
    • ,
  • Johannes A. Langendijk

      Affiliations

    • Department of Radiation Oncology, University Medical Centre Groningen/University of Groningen, The Netherlands

Received 13 May 2009 ,Revised 11 August 2009 ,Accepted 14 August 2009.

References 

  1. IKC. Available from: www.cancerregistry.nl.2009.
  2. Wijnhoven BP, Louwman MW, Tilanus HW, et al. Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s. Eur J Gastroenterol Hepatol. 2002;14:115–122
  3. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg. 2003;185:538–543
  4. Morota M, Gomi K, Kozuka T, et al. Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2009;
  5. Marks LB, Yu X, Vujaskovic Z, et al. Radiation-induced lung injury. Semin Radiat Oncol. 2003;13:333–345
  6. Gagliardi G, Lax I, Rutqvist LE. Partial irradiation of the heart. Semin Radiat Oncol. 2001;11:224–233
  7. Wong R, Malthaner R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev. 2001;CD002092
  8. Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8:226–234
  9. Tsujino K, Hirota S, Endo M, et al. Predictive value of dose–volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys. 2003;55:110–115
  10. Seppenwoolde Y, De Jaeger K, Lebesque JV. In regard to Tsujino et al.: predictive value of dose–volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. IJROBP. 2003;55:110–115Int J Radiat Oncol Biol Phys 2003;56:1208–9
  11. Leong T, Everitt C, Yuen K, et al. A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. Radiother Oncol. 2006;78:254–261
  12. Gondi V, Bradley K, Mehta M, et al. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007;67:187–195
  13. Moureau-Zabotto L, Touboul E, Lerouge D, et al. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2005;63:340–345
  14. Konski A, Doss M, Milestone B, et al. The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2005;61:1123–1128
  15. Hong TS, Killoran JH, Mamede M, et al. Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning. Int J Radiat Oncol Biol Phys. 2008;72:1612–1618
  16. Vrieze O, Haustermans K, De Wever W, et al. Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?. Radiother Oncol. 2004;73:269–275
  17. Sobin LH, Fleming ID. TNM classification of malignant tumors. 5th ed. Union Internationale Contre le Cancer and the American Joint Committee on Cancer; 1997. Cancer 1997;80:1803–4.
  18. Nestle U, Kremp S, Grosu AL. Practical integration of [18F]-FDG-PET and PET–CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol. 2006;81:209–225
  19. International Commission on Radiation Units and Measurements (ICRU) ICRU Report 50: prescribing, recording and reporting photon beam therapy; 2009.
  20. Semenenko VA, Li XA. Lyman–Kutcher–Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data. Phys Med Biol. 2008;53:737–755
  21. Kato H, Miyazaki T, Nakajima M, et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer. 2005;103:148–156
  22. Mamede M, El Fakhri G, Abreu-e-Lima P, et al. Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation. Ann Nucl Med. 2007;21:553–562
  23. Patel AA, Wolfgang JA, Niemierko A, et al. Implications of respiratory motion as measured by four-dimensional computed tomography for radiation treatment planning of esophageal cancer. Int J Radiat Oncol Biol Phys. 2009;74:290–296
  24. Yuan S, Yu Y, Chao KS, et al. Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer. J Nucl Med. 2006;47:1255–1259
  25. Schreurs LM, Pultrum BB, Koopmans KP, et al. Better assessment of nodal metastases by PET/CT fusion compared to side-by-side PET/CT in oesophageal cancer. Anticancer Res. 2008;28:1867–1873
  26. Kato H, Kuwano H, Nakajima M, et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer. 2002;94:921–928
  27. Zhong X, Yu J, Zhang B, et al. Using (18)F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 2009;73:136–141
  28. Button MR, Morgan CA, Croydon ES, et al. Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2009;73:818–823
  29. Gagliardi G, Lax I, Ottolenghi A, et al. Long-term cardiac mortality after radiotherapy of breast cancer – application of the relative seriality model. Br J Radiol. 1996;69:839–846
  30. Vesprini D, Ung Y, Dinniwell R, et al. Improving observer variability in target delineation for gastro-oesophageal cancer – the role of (18F)fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography. Clin Oncol (R Coll Radiol). 2008;20:631–638

PII: S0167-8140(09)00464-2

doi: 10.1016/j.radonc.2009.08.030

Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 447-453 , December 2009

Article Tools

* Image Usage & Resolution